1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one

C25H25BrN2O2 — CID 57297442

IUPAC1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one
SMILESC=CC(=O)N1CC[C@]2(c3cccc(OC)c3)Cc3[nH]c4c(Br)cccc4c3CC2C1
InChIInChI=1S/C25H25BrN2O2/c1-3-23(29)28-11-10-25(16-6-4-7-18(12-16)30-2)14-22-20(13-17(25)15-28)19-8-5-9-21(26)24(19)27-22/h3-9,12,17,27H,1,10-11,13-15H2,2H3/t17?,25-/m1/s1
InChIKeyRODIFEYZILVUQF-DNIBEGIYSA-N
MW465.39 g/mol
LogP5.01
Rot. Bonds3

About 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one

1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one (PubChem CID 57297442) has the molecular formula C25H25BrN2O2 and a molecular weight of 465.39 g/mol. Its IUPAC name is 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one.

Molecular Properties

Compound Name1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one
PubChem CID57297442
Molecular FormulaC25H25BrN2O2
Molecular Weight465.39 g/mol
Exact Mass464.11
IUPAC Name1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one
SMILESC=CC(=O)N1CC[C@]2(c3cccc(OC)c3)Cc3[nH]c4c(Br)cccc4c3CC2C1
InChIInChI=1S/C25H25BrN2O2/c1-3-23(29)28-11-10-25(16-6-4-7-18(12-16)30-2)14-22-20(13-17(25)15-28)19-8-5-9-21(26)24(19)27-22/h3-9,12,17,27H,1,10-11,13-15H2,2H3/t17?,25-/m1/s1
InChIKeyRODIFEYZILVUQF-DNIBEGIYSA-N
XLogP5.01
TPSA45.33 Ų
H-Bond Donors1
H-Bond Acceptors2
Rotatable Bonds3
Heavy Atoms30
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500465.39
LogP ≤ 55.01
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one?
The IUPAC name of 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one (CID 57297442) is 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one.
What is the SMILES notation for 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one?
The canonical SMILES for 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one is C=CC(=O)N1CC[C@]2(c3cccc(OC)c3)Cc3[nH]c4c(Br)cccc4c3CC2C1.
What is the InChIKey of 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one?
The InChIKey is RODIFEYZILVUQF-DNIBEGIYSA-N. The full InChI is InChI=1S/C25H25BrN2O2/c1-3-23(29)28-11-10-25(16-6-4-7-18(12-16)30-2)14-22-20(13-17(25)15-28)19-8-5-9-21(26)24(19)27-22/h3-9,12,17,27H,1,10-11,13-15H2,2H3/t17?,25-/m1/s1.
What are the key properties of 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one?
1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one has a molecular weight of 465.39 g/mol, XLogP of 5.01, 3 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(4aS)-7-bromo-4a-(3-methoxyphenyl)-3,4,5,6,11,11a-hexahydro-1H-pyrido[4,3-b]carbazol-2-yl]prop-2-en-1-one is sourced from PubChem (CID 57297442), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).